Web13 Jun 2024 · It also showcases early work by SMOC Therapeutics, which was founded in late 2024 with $7.5 million in seed funding to treat innate immune-driven diseases by … WebWhat is it really like to work at SMOC Therapeutics? Join the community to connect with real employees and see what other professionals are saying about their companies.

Smoc Therapeutics - Crunchbase Company Profile

WebSMOC Therapeutics Jan 2024 - Nov 202411 months Research Fellow, Head of Discovery Immunology Alkermes Inc. Oct 2016 - Dec 20242 years 3 months Waltham, MA Associate … WebSmoc Therapeutics, Inc. is a corporation in Natick, Massachusetts. The employer identification number (EIN) for Smoc Therapeutics, Inc. is 821286493. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. It is one of the corporates which submit 10-K filings with the SEC. javascript programiz online

Michael Turner - Executive Director of Immunology - LinkedIn

WebThe innate immune system is our first line of defense against microbial invaders, and a protein called NLRP3 is one of its loudest alarms. When triggered by an intruder, NLRP3 proteins change shape and begin forming a large structure called the inflammasome , which in turn activates a flurry of molecules that beckon the immune system to send backup. … Web8 Jan 2024 · smoctherapeutics.com Claim your profile to get in front of buyers, investors, and analysts. Submit Your Analyst Briefing Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Learn more. Overview & Products Financials People Customers Total Raised $7.5M Funding, Valuation & Revenue 1 Fundings WebTarsa Therapeutics USA Private Tarsa Therapeutics is developing OSTORA?, a novel oral formulation of calcitonin for the treatment and prevention of postmenopausal … javascript print image from url